Astemizole

In the US, Astemizole (astemizole systemic) is a member of the drug class antihistamines and is used to treat Allergic Urticaria, Allergies and Urticaria.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R06AX11

CAS registry number (Chemical Abstracts Service)

0068844-77-9

Chemical Formula

C28-H31-F-N4-O

Molecular Weight

458

Therapeutic Categories

Antiallergic agent

Histamine receptor antagonist (antihistaminic agent)

Chemical Name

1-(p-fluorobenzyl)-2-[[1-(p-methoxyphenethyl)-4-piperidyl]amino]benzimidazole (WHO)

Foreign Names

Generic Names

  • Astemizole (OS: BAN, USAN)
  • Astémizole (OS: DCF)
  • BRN 4830190 (IS)
  • R 43512 (IS)
  • UNII-7HU6337315 (IS)
  • Astemizol (PH: Ph. Eur. 6)
  • Astemizole (PH: BP 2011, Ph. Eur. 6, USP 34)
  • Astémizole (PH: Ph. Eur. 6)
  • Astemizolum (PH: Ph. Eur. 6)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Severe allergies and anaphylaxis: Learn how epinephrine can save a life. Watch Video

Close
Hide
(web3)